A recognition that supports the advancement and market readiness of our pediatric heart valve reconstruction technology.
We are truly honored and excited to share that AVaTAR MedTech has been selected as one of the winners of the 2025 SWPDC–AAP SOATT Pediatric Device Prize. This recognition from the Southwest National Pediatric Device Consortium (SWPDC) and the American Academy of Pediatrics SOATT is a meaningful milestone in our journey.
We deeply appreciate the support of SWPDC, as this award will play a key role in helping us advance the development of our device and accelerate our path to market entry, bringing us closer to improving the lives of children around the world living with heart valve disease.
According to the official announcement, AVaTAR MedTech was recognized for its surgical tools for pediatric aortic valve trileaflet reconstruction using autologous tissue, alongside fellow SOATT winners SMOLTAP and SOU winner Zorroflow. We congratulate all the awardees for their commitment to advancing care for the youngest patients.
We extend our heartfelt thanks to SWPDC and the AAP for this incredible recognition and support.
This award strengthens our mission and fuels our vision to deliver life-changing pediatric heart innovations globally.
